Predes Patent on Amas Continen to Expire Soon

Doctors once shied away from using opioids to treat chronic pain, citing the risk of addiction. But in the 1970s, a new generation of doctors started to argue that opioids should be reconsidered, and that allowing terminal patients to suffer in agony is torturous. As the palliative care movement grows, Purdue Frederick, a small pharmaceutical company, sees an opportunity to bring opioids out of the shadows and to the masses...to devastating effect.

You can binge all episodes of American Innovations exclusively and ad-free on Wondery+. Find Wondery+ in the Wondery App or on Apple Podcasts.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.